Targeting persistent fatigue with tailored versus generic self-management strategies in adolescents and young adults with a fatigue syndrome or rheumatic condition: A randomized crossover trial. — CFSMEATLAS
E1 ReplicatedModerate confidencePEM not requiredRCTPeer-reviewedMachine draft
Standard · 3 min
Targeting persistent fatigue with tailored versus generic self-management strategies in adolescents and young adults with a fatigue syndrome or rheumatic condition: A randomized crossover trial.
Vroegindeweij, Anouk, Wulffraat, Nico M, Van De Putte, Elise M et al. · British journal of health psychology · 2024 · DOI
Quick Summary
This study tested two different approaches to help young people (ages 12-29) with persistent fatigue manage their symptoms: personalized lifestyle advice tailored to each person, and generic dietary guidelines. Over 12 weeks each, both approaches similarly improved fatigue levels, confidence in managing their condition, and quality of life. The improvements were small but meaningful, suggesting these self-help strategies could be useful while waiting for other treatments like therapy.
Why It Matters
This study addresses a critical clinical gap by evaluating practical, accessible self-management strategies for adolescents and young adults with fatigue syndromes. The finding that both tailored and generic approaches produce meaningful improvements suggests that symptom management support may benefit young patients with ME/CFS while they await evidence-based treatments, reducing burden on specialized services and improving quality of life during waiting periods.
Observed Findings
Fatigue severity improved significantly in both intervention groups (p<0.015).
Quality of life improvements in physical and emotional functioning subscales were clinically relevant in the study population.
Tailored and generic self-management strategies showed equivalent effectiveness (no significant between-group differences).
Intervention order did not significantly affect improvement levels (p-range: 0.242–0.984).
Feasibility and adherence ratings were similar for both strategies (M≈6.45 and 7.67/10, respectively).
Inferred Conclusions
Both tailored lifestyle advice and generic dietary guidance produce similar improvements in fatigue and quality of life, suggesting that the act of receiving structured self-management support may matter more than personalization level.
Self-management interventions represent a feasible, acceptable option for bridging waiting times for guided therapies such as CBT in young patients with fatigue syndromes.
The accessibility of generic dietary advice makes it a practical alternative when tailored interventions are resource-intensive.
Remaining Questions
Does efficacy persist beyond the 12-week intervention period, and what are the trajectories of symptom relapse or continued improvement at 6–12 months follow-up?
What This Study Does Not Prove
This study does not establish that these interventions are curative or superior to established treatments like cognitive behavioral therapy; it only suggests they may help manage symptoms and bridge waiting times. The mixed cohort (fatigue syndrome plus rheumatic conditions) limits conclusions specific to ME/CFS. Dropouts and completion rate (46/60) mean results may not reflect intent-to-treat populations, and the 12-week timeframe does not assess long-term sustainability.
Tags
Symptom:Fatigue
Phenotype:Pediatric
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
How do these interventions perform specifically in ME/CFS populations versus other fatigue syndromes and rheumatic conditions—are the mixed cohort results generalizable?
What mechanisms underlie equivalent improvements from tailored versus generic approaches—is change driven by behavioral consistency, therapeutic attention, or expectancy effects?
What baseline patient characteristics predict better response to either strategy, and are there subgroups for whom personalization provides added benefit?